Is serum copeptin a modifiable biomarker in autosomal dominant polycystic kidney disease?

The availability of disease-modifying drugs for the management of autosomal dominant polycystic kidney disease (ADPKD) has accelerated the need to accurately predict renal prognosis and/or treatment response in this condition. Arginine vasopressin (AVP) is a critical determinant of postnatal kidney...

Descripción completa

Detalles Bibliográficos
Autores principales: Tasneem, Moomal, Mannix, Carly, Wong, Annette, Zhang, Jennifer, Rangan, Gopala
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838414/
https://www.ncbi.nlm.nih.gov/pubmed/29527508
http://dx.doi.org/10.5527/wjn.v7.i2.51

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838414/
https://www.ncbi.nlm.nih.gov/pubmed/29527508
http://dx.doi.org/10.5527/wjn.v7.i2.51

Ejemplares similares